See All Slides - tctmd.com

Slides

Presentation THT 2025

Assessing the Impact of Hospital Volume Thresholds on In-Hospital Mortality Among Heart Transplant Patients: An Analysis of the National Inpatient Sample (2017-2021)

Presenter: Viet Nghi Tran

February 11, 2025

Presentation THT 2025

Increasing Reach: Using TeleHealth to Get STRONGer

Presenter: Daniel Bensimhon

February 11, 2025

Presentation THT 2025

Mechanisms by Which Cardiometablic Drugs Help People Feel Better

Presenter: Barry Borlaug

February 11, 2025

Presentation THT 2025

Increasing Access: Reducing Referral Delay in Ambulatory Advanced HF Patients

Presenter: Nir Uriel

February 11, 2025

Presentation Controversies and Advances 2025

MINOCA, ANOCA and INOCA: What’s in a Name!

Presenter: John Beltrame

January 31, 2025

Presentation Controversies and Advances 2025

Changing ABO Blood Type During Ex Vivo Perfusion

Presenter: Fardad Esmailian

January 31, 2025

Presentation Controversies and Advances 2025

The role of double-blind sham-controlled trials in interventional cardiology

Presenter: Rasha Al-Lamee

January 31, 2025

Presentation Controversies and Advances 2025

The Guidelines are Wrong: Everyone with Severe Proximal or Mid Vessel CAD Should Have PCI Regardless of Symptoms

Presenter: Paul S. Teirstein

January 31, 2025

Presentation Controversies and Advances 2025

Antianginals or Stents are Reasonable Alternatives for Patients with Symptomatic CAD

Presenter: Rasha Al-Lamee

January 31, 2025

Presentation Controversies and Advances 2025

Angiography-Derived Coronary Physiology: Even Better than the Real Thing?

Presenter: William F. Fearon

January 31, 2025

Advertisement

Slides

Assessing the Impact of Hospital Volume Thresholds on In-Hospital Mortality Among Heart Transplant Patients: An Analysis of the National Inpatient Sample (2017-2021)

Increasing Reach: Using TeleHealth to Get STRONGer

Mechanisms by Which Cardiometablic Drugs Help People Feel Better

Increasing Access: Reducing Referral Delay in Ambulatory Advanced HF Patients

MINOCA, ANOCA and INOCA: What’s in a Name!

Changing ABO Blood Type During Ex Vivo Perfusion

The role of double-blind sham-controlled trials in interventional cardiology

The Guidelines are Wrong: Everyone with Severe Proximal or Mid Vessel CAD Should Have PCI Regardless of Symptoms

Antianginals or Stents are Reasonable Alternatives for Patients with Symptomatic CAD

Angiography-Derived Coronary Physiology: Even Better than the Real Thing?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content